HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - ANVISA Registration 10345162547
Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162547 and manufactured by manufacturer not specified. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Sep 15, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, GUANGZHOU WONDFO BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10345162547
25351059326202551
01449930000190
Company Information
Dates and Status
Sep 15, 2025
15/09/2035
09/18/2025 19:00:01
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Luminis FIA NT-proBNP
QINGDAO HIGHTOP BIOTECH CO.,LTD.
80474870164
Sep 08, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Luminis FIA NT-proBNP
Not specified
80474870164
Sep 08, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Família de Reagentes Finecare NT-proBNP
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410148
Sep 08, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Família de Reagentes Finecare NT-proBNP
Not specified
80537410148
Sep 08, 2025
PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
BIOCLIN POCT FIA NT-ProBNP
QUIBASA QUÍMICA BÁSICA LTDA
10269360478
Sep 01, 2025

